drugset / Trial / NCT03204305

Brain Imaging of Cannabinoid Receptors

NCT03204305

Non-randomizedParallel-groupSingle-blindBasic science

Summary

All participants will be healthy volunteers and all procedures will be completed for research purposes only. Two groups will be recruited, females who use cannabis (marijuana, MJ), and female who do not use cannabis (controls). Female MJ users will be enrolled in a protocol that includes an outpatient drug administration session and a 4-day/3-night inpatient stay on the Johns Hopkins Bayview Clinical Research Unit (CRU). During outpatient visits, MJ users will have an MRI, and complete MJ self-administration and cognitive performance sessions. MJ users will then reside on the CRU,and complete MJ abstinence, and self-report instruments for withdrawal discomfort. A positron emission tomography (PET) scan of brain cannabinoid type 1 receptors will also be completed. Non-users will complete MRI, PET imaging and cognitive testing under an outpatient protocol (no MJ administration).

Timeline

Start
2017-09-14
Primary completion
2020-03-31
Completion
2020-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator 11C-OMAR Diagnostic / imaging agent 740 mbq
Comparator Cannabis Traditional medicine (herbal / TCM) 0 mg
Comparator Cannabis Traditional medicine (herbal / TCM) 25 mg

Indications